Neonatal Insulin Replacement Therapy in Europe

This trial has now closed.




A multi-centre, randomised controlled study of early insulin replacement in very low birth weight infants (VLBW <1500g). 500 children will be randomised to receive either a continuous infusion of insulin (0.05 u/kg/hr) from within 24 hours of birth and for the first 7 days, or to act as controls and receive standard neonatal care.


Inclusion Criteria

Patient Exclusions


If you require any help, please contact:

NIRTURE Study Coordinator
Tel: +44 (0) 1223 763130
Fax: +44 (0) 1223 336996
Email: nirture@paed.cam.ac.uk

Cambridge University  

Randomisation service provided by: Sealed Envelope™.com